Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Implications of Stress Hyperglycemia Ratio for the Prognosis of Coronary Microvascular Dysfunction in Patients with Chronic Coronary Syndrome

NCT06698432 is registered in ClinicalTrials.gov with Ya-Wei Xu as lead sponsor.

NCT NCT06698432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06698432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Implications of Stress Hyperglycemia Ratio for the Prognosis of Coronary Microvascular Dysfunction in Patients with Chronic Coronary Syndrome
Lead sponsor
Ya-Wei Xu
Phase
Observational
Overall status
Completed
Start date
June 1, 2015
Completion date
June 1, 2019
Enrollment
379 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic coronary syndrome, coronary microvascular dysfunction (cmd), index of microvascular resistance, prognosis